Development of Lu-DOTA-anti-CD20 for radioimmunotherapy.

MLA

Yousefnia, Hassan, et al. “Development of Lu-DOTA-Anti-CD20 for Radioimmunotherapy.” Journal of Radioanalytical & Nuclear Chemistry, vol. 287, no. 1, Jan. 2011, pp. 199–209. EBSCOhost, https://doi.org/10.1007/s10967-010-0676-4.

APA

Yousefnia, H., Radfar, E., Jalilian, A., Bahrami-Samani, A., Shirvani-Arani, S., Arbabi, A., & Ghannadi-Maragheh, M. (2011). Development of Lu-DOTA-anti-CD20 for radioimmunotherapy. Journal of Radioanalytical & Nuclear Chemistry, 287(1), 199–209. https://doi.org/10.1007/s10967-010-0676-4

Chicago

Yousefnia, Hassan, Edalat Radfar, Amir Jalilian, Ali Bahrami-Samani, Simindokht Shirvani-Arani, Azim Arbabi, and Mohammad Ghannadi-Maragheh. 2011. “Development of Lu-DOTA-Anti-CD20 for Radioimmunotherapy.” Journal of Radioanalytical & Nuclear Chemistry 287 (1): 199–209. doi:10.1007/s10967-010-0676-4.